Page 84 - Looking Statement News Today

Gambier Gold Corp. is pleased to announce that it has closed its private placement of 5,333,334 units at a price of $0.15 per unit originally announced on March 11, 2021, for gross proceeds of $800,000.10. Each unit consists of one common share and one share purchase warrant. Each share purchase warrant is exercisable for a period of 2 years into a common share at $0.23 stated Michael Schuss, CEO. commented Quinton … Gambier Gold Corp. (TSX-V:GGAU) (the “Company”) is pleased to announce t...

Article content Vancouver, British Columbia–(Newsfile Corp. – April 19, 2021) –  Kodiak Copper Corp. (TSXV: KDK) (the “Company” or “Kodiak”) is pleased to announce that it has entered into a purchase agreement to acquire a 100% interest in the Axe Copper-Gold Property (“Axe”) from Orogen Royalties (“Orogen”, TSXV:OGN). Axe is contiguous with Kodiak’s 100% owned MPD Project (“MPD”) in Southern British Columbia in the prolific Quesnel Trough (see Figure 1), with year-...

Press release content from Business Wire. The AP news staff was not involved in its creation. Merck to Discontinue Development of MK-7110 for COVID-19 April 15, 2021 GMT KENILWORTH, N.J.--(BUSINESS WIRE)--Apr 15, 2021-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the discontinuation of development of MK-7110 (formerly known as CD24Fc) for the treatment of hospitalized patients with COVID-19. Merck acquired MK-7110 in December 2020 through its acquisitio...

Merck and Ridgeback Biotherapeutics Provide Update on Progress of Clinical Development Program for Molnupiravir, an Investigational Oral Therapeutic for the Treatment of Mild-to-Moderate COVID-19 Phase 3 MOVe-OUT Study of Molnupiravir in Outpatients to Proceed, Phase 23 MOVe-IN Study in Hospitalized Patients Will Not Proceed Merck known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today provided an update on the clinical development program for molnupiravir an inve...

/PRNewswire/ -- Eltek Ltd. (NASDAQ: ELTK), a global manufacturer and supplier of technologically advanced solutions in the field of printed circuit boards,...

Pieris Pharmaceuticals, Inc.: Pieris Pharmaceuticals Presents Updated Phase 1 Monotherapy Data for 4-1BB/HER2 Bispecific Cinrebafusp Alfa and Preclinical Data for 4-1BB/PD-L1 Bispecific PRS-344/S095012 at 2021 AACR Annual Meeting Durable anti-tumor activity in heavily pre-treated patient population ?including "cold" and HER2-low expressing tumors Dose-dependent immune activation and 4-1BB modulation in both HER2-high and HER2-low expressing patients PRS-344/S095012 preclinical BOSTON, MA / ACC...

Theralase Technologies Inc.: Theralase Commences Collaborative Research with National Microbiology Laboratory for Development of Coronavirus Vaccine ® Technologies Inc. (" TSXV:TLT)( OTCQB:TLTFF), a clinical stage pharmaceutical company focused on the research and development of light activated Photo Dynamic Compounds (" PDC") and their associated drug formulations to safely and effectively destroy various cancers, bacteria and viruses, announced today that it has executed a Collaborative Rese...

 New Found Gold Corp. (" New Found" or the " Company") (TSXV: NFG) (OTC: NFGFF) is pleased to announce that it has completed its previously announced non-brokered private placement of 2,857,000 common shares of the Company that qualify as "flow-through shares" for the purposes of the Income Tax Act (Canada) (the " FT Shares")  at a price of $5.25 per FT Share (the " Financing"), for gross proceeds to New Found of $14,999,250. The FT Shares have a hold period of four months and one day from ...

Organon Announces Proposed Senior Notes Offering Search jobs Organon Announces Proposed Senior Notes Offering KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Organon Finance 1 LLC plans to offer, subject to market conditions, euro-denominated senior secured notes due 2028, U.S. dollar-denominated senior secured notes due 2028 and U.S. dollar-denominated senior unsecured notes due 2031 (collect...

106.46 *Note that the host structures are interpreted to be steeply dipping and true widths are estimated to be 70% to 80% of reported intervals. Intervals are calculated at a 1 g/t Au cut-off grade; grades have not been capped in the averaging. Multiple intervals encountered in drill holes NFGC-21-74 and NFGC-21-122 provide further confirmation of high-grade, near surface gold mineralization at the north end of Keats. These results include 45.6g/t Au over 4.05m in hole NFGC-21-74 and 69.2g/t A...